Jaime FJC, Roque GW, Quintero SY, Valdés CF, Castellanos HL

Language: Spanish
References: 21
Page: 1-8
PDF size: 430.94 Kb.

ABSTRACT

Introduction: Brucellosis is the most frequent zoonosis, produced by the genus brucella, which affects several species of mammals, including human beings. It is transmitted to persons by direct contact with infected animals, by their excreta or by ingestion of unpasteurized products. In recent years, an increase has been described in immunocompromised patients.
Objectives: To describe the reactivation of brucellosis in a hematopoietic transplant recipient patient, its course and management.
Case presentation: A patient with Hodgkin's lymphoma and a history of brucellosis is presented; that she received a myeloablative autologous hematopoietic transplant. After haematological recovery, she started with symptoms of fever, diaphoresis, joint pain and hepato-splenomegaly. She was diagnosed with brucellosis, so treatment with doxycycline and rifampin was started, which eliminated the symptoms and made the evolutionary tests negative.
Conclusions: Brucellosis can be asymptomatic for months or years and after immunosuppression it can be reactivated in transplanted patients. Suspicion and prompt treatment can bring about a cure and avoid complications.

REFERENCES

1. Díaz A. Epidemiología de la brucelosis causada por Brucella melitensis, Brucella suis y Brucella abortus en animales domésticos. Rev sci tech Off int. Epiz 2013 [acceso 20/06/2021];32(1):43-51. Disponible en: https://www.oie.int/doc/ged/D12404.PDF1.

2. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929. DOI: https://10.1371/journal.pntd.00019292.

3. Khurana SK, Sehrawat A, Tiwari R, Prasad M, Gulati B, Shabbir MZ, et al. Bovine brucellosis- a comprehensive review. Vet Q. 2021;1;41(1):61-88. DOI: https://10.1080/01652176.2020.18686163.

4. Ghanbari MK, Gorji HA, Behzadifar M, Sanee N, Mehedi N, Bragazzi NL. One health approach to tackle brucellosis: a systematic review. Trop Med Health. 2020;20;48:86. DOI: https://10.1186/s41182-020-00272-14.

5. Kracalik IT, Abdullayev R, Asadov K, Ismayilova R, Baghirova M, Ustun N, et al. Human Brucellosis Trends: Re-emergence and Prospects for Control Using a One Health Approach in Azerbaijan (1983-2009). Zoonoses Public Health. 2016;63(4):294-302. DOI: https://10.1111/zph.122295.

6. Ntirandekura JB, Matemba LE, Kimera SI, Muma JB, Karimuribo ED. Association of Brucellosis with Abortion Prevalence in Humans and Animals in Africa: A Review. Afr J Reprod Health. 2018;22(3):120-136. DOI: https://10.29063/ajrh2018/v22i3.136.

7. Dirección General de Vigilancia de la Salud. Ministerio de Salud Pública y Bienestar Social. Guía Nacional de Vigilancia y Control de Enfermedades Sistema Nacional de Vigilancia Epidemiológica Paraguay. 2015. Paraguay: DGVS; 2015. p.37-43. [acceso 20/06/2021]; Disponible en: Disponible en: http://dgvs.mspbs.gov.py/files/guiaNacional/Guia-Vigilancia-2015.pdf 7.

8. Meng F, Pan X, Tong W. Rifampicin versus streptomycin for brucellosis treatment in humans: A meta-analysis of randomized controlled trials. PLoS One. 2018;13(2):e0191993. DOI: https://10.1371/journal.pone.01919938.

9. Ögredici Ö, Erb S, Langer I, Pilo P, Kerner A, Haack HG, et al. Brucellosis reactivation after 28 years. Emerg Infect Dis. 2010;16(12):2021-2 DOI: https://10.3201/eid1612.1006789.

10. Piedrahita D, Martinez-Valencia AJ, Agudelo Rojas OL, Tafur E, Rosso F. Fatal Brucellosis Infection in a Liver Transplant Patient: A Case Report and Review of the Literature. Case Rep Infect Dis. 2021;2021:1519288. DOI: https://10.1155/2021/151928810.

11. Al-Anazi KA, Jafar SA, Al-Jasser AM, Al-Omar H, Al-Mohareb FI. Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report. Cases J. 2009;2(1):91. DOI: https://10.1186/1757-1626-2-9111.

12. Inayat F, Mahboob M, Ali NS, Bokhari SRA, Ashraf A. Brucellosis in renal transplant recipients: a comparative review of 5 cases. BMJ Case Rep. 2018;2018:bcr2018225865. DOI: https://10.1136/bcr-2018-22586512.

13. Rabiei MM, Imanzade F, Hatami F, Hesami H, Irvani SSN, Alavi Darazam I. Brucellosis in transplant recipients: A systematic review. Transpl Infect Dis. 2021;23(4):e13604. DOI: https://10.1111/tid.1360413.

14. Rahdar HA, Kodori M, Salehi MR, Doomanlou M, Karami-Zarandi M, Jasemi S, et al. Multiple Myeloma or Brucellosis: A Case Report. Infect Disord Drug Targets. 2020;20(1):102-5. DOI: https://10.2174/187152651966619030712304714.

15. Al-Anazi KA, Al-Jasser AM. Brucella bacteremia in patients with acute leukemia: a case series. J Med Case Rep. 2007;1:144. DOI: https://10.1186/1752-1947-1-14415.

16. Al-Otaibi FE. Acute acalculus cholecystitis and hepatitis caused by Brucella melitensis. J Infect Dev Ctries. 2010; 4(7):464-7. DOI: https://10.3855/jidc.61816.

17. Giambartolomei GH, Delpino MV. Immunopathogenesis of Hepatic Brucellosis. Front Cell Infect Microbiol. 2019;9:423. DOI: https://10.3389/fcimb.2019.0042317.

18. Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, Sadeghipour P. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012;10(10): DOI: https://10.1002/14651858.CD007179.pub218.

19. Glowacka P, Zakowska D, Naylor K, Niemcewicz M, Bielawska-Drózd A. Brucella - Virulence Factors, Pathogenesis and Treatment. Pol J Microbiol. 2018;67(2):151-61. DOI: https://10.21307/pjm-2018-02919.

20. Bukhari EE. Pediatric brucellosis. An update review for the new millennium. Saudi Med J. 2018;39(4):336-41. DOI: https://10.15537/smj.2018.4.2189620.

21. Qasim SS, Alshuwaier K, Alosaimi MQ, Alghafees MA, Alrasheed A, Layqah L, et al. Brucellosis in Saudi Children: Presentation, Complications, and Treatment Outcome. Cureus. 2020;12(11):e11289 DOI: https://10.7759/cureus.1128921.